ACUTE LYMPHOCYTIC LEUKEMIA
Clinical trials for ACUTE LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental stem cell therapy aims to speed recovery in blood cancer patients
Disease control OngoingThis study tests a new way to grow stem cells from umbilical cord blood to help people with high-risk blood cancers like leukemia and lymphoma recover faster after a bone marrow transplant. About 22 patients will receive the expanded stem cells along with standard chemotherapy an…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated May 26, 2026 10:17 UTC
-
New hope for leukemia patients: drug aims to wipe out hidden cancer cells
Disease control OngoingThis study tests a drug called inotuzumab ozogamicin in 31 adults with a type of leukemia (Ph-negative ALL) who achieved remission after initial chemotherapy but still have tiny amounts of cancer cells (minimal residual disease, or MRD). The goal is to see if the drug can clear t…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 26, 2026 10:16 UTC
-
Could a simple pill boost CAR T-Cell staying power against blood cancers?
Disease control OngoingThis early-phase study tests whether adding the drug duvelisib after CAR T-cell therapy can help the immune cells survive longer and fight non-Hodgkin lymphoma or acute lymphocytic leukemia more effectively. About 42 adults who are eligible for approved CAR T-cell treatments will…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 10:11 UTC
-
Frozen donor marrow trial aims to treat blood cancers
Disease control TerminatedThis study tested a bone marrow transplant using frozen, banked bone marrow from unrelated donors for people with blood cancers like leukemia. The goal was to see if it safely restores healthy blood cells and controls the disease. The trial was withdrawn before enrolling any part…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Ossium Health, Inc. • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
New drug safety check for kids with blood cancer
Disease control OngoingThis study looks at the safety of BESPONSA, a drug already approved for children with a fast-growing blood cancer called ALL. About 10 children under 18 who have not used BESPONSA before will receive the drug as prescribed. Researchers will track side effects and watch for liver …
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Sponsor: Pfizer • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Engineered t cells take aim at Hard-to-Treat blood cancers
Disease control OngoingThis early-phase study tests a new approach for people with B-cell lymphoma or leukemia that has returned or not responded to standard therapy. Researchers take a patient's own immune cells (T cells), modify them in the lab to recognize and attack cancer cells carrying the CD19 p…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 19, 2026 11:59 UTC